BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. Announce Plans to Merge to Become Nipro Diagnostics, Inc.


6/9/2010 8:26:24 AM

FORT LAUDERDALE & MIRAMAR, Fla.--(BUSINESS WIRE)--Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.

Home Diagnostics, Inc., based in Fort Lauderdale, Florida, manufactures and markets the TRUE brand of quality, high-performance blood glucose monitoring systems. Home Diagnostics is the co-brand supplier of blood glucose monitoring systems for leading national retail pharmacies, pharmacy wholesalers, medical products distributors and mail-order suppliers. Nipro Diabetes Systems, located in Miramar, Florida, is the manufacturer and marketer of the Amigo® Insulin Pump.

The merger of the two companies results in a comprehensive diabetes monitoring and insulin management product portfolio, which few companies offer. This portfolio will help to ensure that patients and their healthcare professionals have easy access to the high-quality diabetes monitoring and management tools they need to improve quality of life.

Both companies share a vision of making diabetes monitoring and management more affordable and are already well-positioned in the quality-value segment of their respective categories.

“Our mission at Home Diagnostics has always been to make high-performance blood glucose monitoring technology more affordable to people with diabetes,” said Joseph Capper, president of Home Diagnostics, Inc. “Merging with Nipro Diabetes Systems helps us extend this mission to the insulin pump category.”

The name change to Nipro Diagnostics, Inc. is effective immediately for Home Diagnostics. The merger of the two companies is expected to be completed by the end of the year.

Contact:

Home Diagnostics, Inc. Joseph Capper, President, 800-342-7226 jcapper@hdidiabetes.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->